Table 4 Distribution of the first onset date of adverse effects from the start of pregabalin medication
First onset date of adverse effects | N (% of adverse effect developed patients) |
|---|---|
≤2 weeks | 46 (73.0 %) |
>2 weeks–≤1 month | 9 (14.3 %) |
>1 month–≤2 months | 1 (1.6 %) |
>2Â months | 7 (11.1Â %) |